Please try another search
Panion & Bf Biotech Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 499.49 million compared to TWD 408.53 million a year ago. Net income was TWD 43.87 million compared to TWD 22.69 million a year ago. Basic earnings per share from continuing operations was TWD 0.51 compared to TWD 0.26 a year ago. Diluted earnings per share from continuing operations was TWD 0.51 compared to TWD 0.26 a year ago.
Period Ending: | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 474.61 | 470.07 | 408.53 | |
Gross Profit | 249.62 | 244.42 | 217.99 | |
Operating Income | 42.68 | 45.38 | 11.6 | |
Net Income | 43.87 | 7.66 | 17.24 | 22.69 |
Period Ending: | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 3078.88 | 3245.75 | 3049.69 | |
Total Liabilities | 1344.76 | 1190.37 | 1372.22 | 1191.72 |
Total Equity | 1888.51 | 1873.53 | 1857.97 |
Period Ending: | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -23.64 | 89.31 | -46.52 | |
Cash From Investing Activities | -60.5 | -58.08 | -38.9 | |
Cash From Financing Activities | -151.71 | 153.96 | -11.57 | |
Net Change in Cash | -233.47 | 185.73 | -97.38 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review